mBio · 2020 · 30 citations · 42 references
PharmacyImmunologyMolecular BiologyAntibody EngineeringMonoclonal AntibodiesVirologyAntibody DiscoveryAntibody FunctionAntibody-antigen RecognitionBispecific AntibodiesMonoclonal Antibody TechnologyTherapeutic Antibody DevelopmentAntibodiesAntibody Glycan RecognitionBispecific Antibody CombinationsBispecific Antibody DiscoveryEpitope SelectionHiv Envelope Glycoprotein AntigensNeutralizationSingle-chain Bispecific Antibodies
Broadly neutralizing antibodies (bNAbs) can prevent a new HIV-1 infection and can at least temporarily suppress an established infection. However, antibody-resistant viruses rapidly emerge in infected persons treated with any single bNAb. Several bispecific antibodies have been developed to increase the breadth of these antibodies, but typically only one arm of these bispecific constructs binds the HIV-1 envelope glycoprotein trimer (Env). Here, we develop and characterize bispecific constructs based on well-characterized V2-glycan and V3-glycan bNAbs and show that at least one member of this class is more potent than its parental antibodies, indicating that they can simultaneously bind both of these epitopes of a single Env trimer. These data show that bispecific antibody-like proteins can achieve greater neutralization potency than the bNAbs from which they were derived.
42
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
Xueling Wu, Zhi-Yong Yang, Yuxing Li et al. · Science · 2010 · 1.8K citations
Broad neutralization coverage of HIV by multiple highly potent antibodies
Laura M. Walker, Michael Huber, Katie J. Doores et al. · Nature · 2011 · 1.5K citations
Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding
Johannes F. Scheid, Hugo Mouquet, Beatrix Ueberheide et al. · Science · 2011 · 1.2K citations · Full text